Joseph J. Wolk
Executive Vice President and Chief Financial Officer, Johnson & Johnson
In the news
J&J Q3 2026 sales rise 5.9% to $25.4B; raises reported sales guidance
Johnson & Johnson reported third-quarter 2026 worldwide sales of $25.4 billion, up 5.9%, and adjusted EPS of $2.59, down 7.5%.
Earnings
J&J schedules Q3 2026 results and investor call for October 13
Johnson & Johnson announced that it will release third-quarter 2026 results around 6:45 a.m.
Earnings
J&J beats Q2 2026 estimates and raises full-year sales and EPS outlook
Johnson & Johnson reported second-quarter 2026 worldwide sales of $25.3 billion, up 6.6% reported, and adjusted EPS of $2.90, up 4.7%.
Earnings